The relevance of drug− nutrient interactions in daily practice continues to grow with the
widespread use of medication. Interactions can involve a single nutrient, multiple nutrients …

Recently, considerable progress has been made in understanding the genetic basis of
dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary …

Purpose: Endogenous metabolic profiles have been shown to predict the fate and toxicity of
drugs such as acetaminophen in healthy individuals. However, the clinical utility of …

Women with polycystic ovary syndrome (PCOS) have increased prevalence of
cardiovascular (CV) risk factors. However, data on the incidence of CV events are lacking in …

Anthracyclines are a well-known cause of cardiotoxicity, but a number of other drugs used to
treat cancer can also result in cardiac and cardiovascular adverse effects. Cardiotoxicity can …

Patients with cancer are now living longer than ever before due to the growth and expansion
of highly effective antineoplastic therapies. Many of these patients face additional health …

What is known and objective The management of drug‐drug interactions–from recognition of
the interaction potential, to addressing the negative consequences–are well‐recognized …

Background: Capecitabine is known to rarely cause raised serum triglycerides (TG). In our
centre, several patients receiving capecitabine developed raised TG levels corresponding to …

Background Capecitabine is a tumor-activated oral fluoropyrimidine used in breast and
colorectal cancer. Hypertriglyceridemia associated with this drug has rarely been reported in …

Introduction Capecitabine, a prodrug of 5-fluorouracil (5-FU), is rarely associated with
severe hypertriglyceridemia. We present a patient with severe capcitabine-induced …